THW Price Forecast & CEF Analysis. Distribution · NAV · Discount · Expense Ratio · RSI · MACD | US Stocks Today
Full metrics table
💰 This is a global healthcare equity closed-end fund (CEF) managed by Aberdeen. It invests in healthcare companies worldwide, including pharmaceuticals, biotechnology, and medical devices, seeking both income and long-term capital appreciation through a monthly stable dividend policy.
It runs 18% of assets on borrowed money.
Borrowing to buy more lifts gains and deepens losses. This is not the same as an ETF tracking 3x a day.
Against the value of what the fund holds it is 4.8% cheaper.
Its holdings are worth $13.49 per share, but it trades at $12.84. That is close to its past-year average (2.0% below value).
Over the past 1 year, roughly in the middle
9% below its 1-year high.
Traded more than usual. That is 148% of its average volume.
Holding long would have lost money
Bought 5 years ago, your return today would be -20.4%. The S&P 500 did +64% over the same period.
Tap to view numbers
Dividends are paid consistently
Pays 10.60% annually in dividends.
Tap to view numbers
Ownership is about average
Institutions hold 14.2%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #635 of 1436 in the industry
Based on market cap of $533M.
FAQ
What kind of CEF is THW?
THW is a closed-end fund (CEF).
What is the distribution yield of THW?
THW's distribution yield is approximately 10.60%, paid out on a regular basis.
What is the 52-week high and low for THW?
THW has recorded a 52-week high of $14.50 and a low of $11.18.